Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Alles Mark J
Relationship:   Director
City:   Summit
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   18,761    

Indirect Shares

   0      
Direct Value   $1,356,420    

Indirect Value

   $0      
Total Shares   18,761      
Total Value   $1,356,420      


Syros Pharmaceuticals, Inc. $18,550 Biomarin Pharmaceutical Inc $1,337,870 Syros Pharmaceuticals, Inc. $18,550 Biomarin Pharmaceutical Inc $1,337,870
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -13.3%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Celgene Corp CELG 2019-11-20 0 2019-11-20 0    Premium*  
            Syros Pharmaceuticals, Inc. SYRS Director 2023-09-16 3,666 2020-05-13 0    Premium*  
            Turning Point Therapeutics, Inc. TPTX Director 2022-08-17 0 2021-06-21 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN Director 2023-05-23 15,095 2022-01-03 0    Premium*  
* Premium Members only  

Records found :    62         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CELG Celgene Corp Chief Commercial OfficerOffice   •       –      –    2012-02-15 3 IO $0.00 $0 I/I 0 2,409 -
CELG Celgene Corp See Remarks   •       –      –    2012-04-14 4 OE $0.00 $0 D/D 3,056 3,056 0 -
CELG Celgene Corp See Remarks   •       –      –    2013-04-13 4 OE $0.00 $0 D/D 4,583 6,737 0 -
CELG Celgene Corp See Remarks   •       –      –    2013-11-01 4 OE $0.00 $0 D/D 10,000 24,946 0 -
CELG Celgene Corp See Remarks   •       –      –    2013-12-27 4 OE $0.00 $0 D/D 7,777 28,221 0 -
CELG Celgene Corp See Remarks   •       –      –    2014-02-12 4 A $0.00 $0 D/D 15,188 39,908 0 -
CELG Celgene Corp See Remarks   •       –      –    2015-02-06 4 A $0.00 $0 D/D 30,404 87,306 0 -
CELG Celgene Corp See Remarks   •       –      –    2015-03-01 4 OE $0.00 $0 D/D 8,334 109,479 0 -
CELG Celgene Corp See Remarks   •       –      –    2015-04-30 4 OE $0.00 $0 D/D 11,200 116,601 0 -
CELG Celgene Corp See Remarks   •       –      –    2015-12-17 4 OE $0.00 $0 D/D 11,670 123,117 0 -
CELG Celgene Corp See Remarks   •       –      –    2016-02-12 4 A $0.00 $0 D/D 25,840 165,525 0 -
CELG Celgene Corp See Remarks   •       •      –    2016-04-29 4 OE $0.00 $0 D/D 11,000 164,636 0 -
CELG Celgene Corp See Remarks   •       •      –    2016-12-02 4 OE $0.00 $0 D/D 6,560 166,134 0 -
CELG Celgene Corp See Remarks   •       •      –    2017-02-14 4 A $0.00 $0 D/D 14,447 177,563 0 -
CELG Celgene Corp See Remarks   •       •      –    2017-07-28 4 OE $0.00 $0 D/D 4,200 175,120 0 -
CELG Celgene Corp See Remarks   •       •      –    2017-12-19 4 OE $0.00 $0 D/D 4,550 177,738 0 -
CELG Celgene Corp See Remarks   •       •      –    2018-02-17 4 OE $0.00 $0 D/D 7,283 186,187 0 -
CELG Celgene Corp CEO, CHAIRMAN OF BOARD   •       •      –    2018-05-04 4 OE $0.00 $0 D/D 3,500 187,627 0 -
CELG Celgene Corp CEO, CHAIRMAN OF BOARD   •       •      –    2018-12-16 4 OE $0.00 $0 D/D 8,929 196,245 0 -
CELG Celgene Corp CEO, CHAIRMAN OF BOARD   •       •      –    2019-03-01 4 OE $0.00 $0 D/D 33,809 226,178 0 -
CELG Celgene Corp CEO, CHAIRMAN OF BOARD   •       •      –    2019-05-02 4 OE $0.00 $0 D/D 15,608 227,886 0 -
CELG Celgene Corp CEO, CHAIRMAN OF BOARD   •       •      –    2019-11-20 4 D $0.00 $0 I/I (6,252) 0 0 -
CELG Celgene Corp CEO, CHAIRMAN OF BOARD   •       •      –    2019-11-20 4 D $0.00 $0 D/D (366,495) 0 0 -
CELG Celgene Corp CEO, CHAIRMAN OF BOARD   •       •      –    2019-11-20 4 A $0.00 $0 D/D 145,229 366,495 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2022-01-03 4 A $0.00 $0 D/D 2,300 2,300 0 -
  62  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us